Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study aims to investigate eradication rate, drug compliance, and adverse events in patients with confirmed Helicobacter pylori infection between tegoprazan, bismuth, metronidazole, and tetracycline for 14 days (TBMT) and PPI, bismuth, metronidazole, and tetracycline for 14 days (LBMT)
Epistemonikos ID: f8526b0fdd522d326f6dd331ce8f72e3e1f02471
First added on: May 08, 2024